Iran says U.S. actions contradict diplomatic norms
01:10
| Home page Health |
|
A drug that halves a woman's risk of breast cancer continues to work long after they stop taking it, say researchers.
Axar.az reports citing BBC.
Anastrozole blocks the production of the hormone oestrogen, which fuels the growth of many breast cancers.
It is already available on the NHS, but researchers at Queen Mary University of London said only a tenth of eligible women were receiving it.
Cancer Research UK said the findings were reassuring.
|
Date
2019.12.12 / 22:14
|
Author
Axar.az
|
